Horvath Susan 4
4 · Panbela Therapeutics, Inc. · Filed Oct 3, 2024
Insider Transaction Report
Form 4
Horvath Susan
V.P. of Finance & CFO
Transactions
- Award
Stock Option (right to buy)
2024-10-01+25,480→ 25,480 totalExercise: $0.39Exp: 2034-10-01→ Common Stock (25,480 underlying)
Footnotes (1)
- [F1]The option fully vests on October 1, 2025, subject to the Reporting Person's continuous service with the Issuer as of the vesting date.